TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MOVE Stock 12 Month Forecast
Average Price Target
CHF177.55
▲(17.43% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Medacta Group SA in the last 3 months. The average price target is CHF177.55 with a high forecast of CHF177.55 and a low forecast of CHF177.55. The average price target represents a 17.43% change from the last price of CHF151.20.
trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +4.76% per trade.
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +6.10% per trade.
Copying Aisyah Noor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.58% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.54% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MOVE Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
3
2
4
7
12
Hold
1
1
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
6
9
14
In the current month, MOVE has received 12Buy Ratings, 2Hold Ratings, and 0Sell Ratings. MOVE average Analyst price target in the past 3 months is 177.55.
Each month's total comprises the sum of three months' worth of ratings.
MOVE Financial Forecast
MOVE Earnings Forecast
The previous quarter’s earnings for MOVE were CHF2.84.
The previous quarter’s earnings for MOVE were CHF2.84.
MOVE Sales Forecast
Next quarter’s sales forecast for MOVE is CHF320.18M with a range of CHF320.18M to CHF320.18M. The previous quarter’s sales results were CHF324.06M. MOVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MOVE has Performed in-line its overall industry.
Next quarter’s sales forecast for MOVE is CHF320.18M with a range of CHF320.18M to CHF320.18M. The previous quarter’s sales results were CHF324.06M. MOVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MOVE has Performed in-line its overall industry.
MOVE Stock Forecast FAQ
What is CH:MOVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Medacta Group SA’s 12-month average price target is 177.55.
What is CH:MOVE’s upside potential, based on the analysts’ average price target?
Medacta Group SA has 17.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Medacta Group SA a Buy, Sell or Hold?
Medacta Group SA has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Medacta Group SA’s share price target?
The average share price target for Medacta Group SA is 177.55. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF177.55 ,and the lowest forecast is CHF177.55. The average share price target represents 17.43% Increase from the current price of CHF151.2.
What do analysts say about Medacta Group SA?
Medacta Group SA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Medacta Group SA?
To buy shares of CH:MOVE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.